This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Cisco ‘Catalyst’ switches cleared by UPC in infringement action by Lionra

By Melissa Ritti ( February 20, 2025, 15:21 GMT | Insight) -- The Unified Patent Court in Hamburg yesterday confirmed the validity of a Lionra Technologies patent directed to data package processing, but found the same patent not infringed by Cisco’s Catalyst 9000 family of network switches, in a win for the US-based tech conglomerate. The parties are also litigating in the US, with briefing completed last month in Lionra’s bid to undo a Texas federal judge’s determination that its agreement with RPX Corp. bars an infringement action over Cisco products containing Intel processors. Oral argument before the US Court of Appeals for the Federal Circuit remains unscheduled.Cisco has prevailed at the Unified Patent Court in infringement proceedings initiated by Lionra Technologies over a method of — and apparatus for — faster package processing of protocol headers across a wireless network....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections